Royal Bank of Canada

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24,810
Total Value
350517986000
Accession Number
0001140361-25-019231
Form Type
13F-HR
Manager Name
Royal Bank of Canada
Data Enrichment
78% identified
19,259 identified5,551 unidentified

Holdings

24,810 positions
Manager:
Search and click to pin securities to the top
Page 314 of 331
69420N502
Shares:
20(-99.4%)
Value:
$1.0M(-99.0%)
032108482
Shares:
35
Value:
$1.0M
Journey Medical Corp
Shares:
250(+0.0%)
Value:
$1.0M(+0.0%)
U.S. GOLD CORP.
Shares:
156
Value:
$1.0M
456948116
Shares:
25000(+0.0%)
Value:
$1.0M(+0.0%)
Paysign, Inc.
Shares:
581(-50.1%)
Value:
$1.0M(-66.7%)
94419LAF8
Shares:
0
Value:
$1.0M(+0.0%)
82889N863
Shares:
49(-89.1%)
Value:
$1.0M(-88.9%)
TScan Therapeutics, Inc.
Shares:
1115(-49.9%)
Value:
$1.0M(-85.7%)
NOVONIX Ltd
Shares:
730(+0.0%)
Value:
$1.0M(+0.0%)
707569AU3
Shares:
0
Value:
$1.0M(+0.0%)
500767835
Shares:
88(-99.0%)
Value:
$1.0M(-99.2%)
WILLAMETTE VALLEY VINEYARDS INC
Shares:
100(+0.0%)
Value:
$1.0M
Hesai Group
Shares:
43
Value:
$1.0M
Kyverna Therapeutics, Inc.
Shares:
743(-53.5%)
Value:
$1.0M(-83.3%)
HARVARD BIOSCIENCE INC
Shares:
2184(-45.7%)
Value:
$1.0M(-87.5%)
185053402
Shares:
569(+0.0%)
Value:
$1.0M(+0.0%)
NOODLES & Co
Shares:
1058(+160.6%)
Value:
$1.0M
EMPIRE PETROLEUM CORP
Shares:
249(-61.0%)
Value:
$1.0M(-80.0%)
LEAP THERAPEUTICS, INC.
Shares:
2743(-58.5%)
Value:
$1.0M(-94.7%)